Vir Biotechnology Inc (VIR)
Total asset turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 86,180 | 1,615,800 | 1,095,420 | 76,368 | 8,091 |
| Total assets | US$ in thousands | 1,919,060 | 2,802,090 | 1,954,270 | 918,761 | 512,071 |
| Total asset turnover | 0.04 | 0.58 | 0.56 | 0.08 | 0.02 |
December 31, 2023 calculation
Total asset turnover = Revenue ÷ Total assets
= $86,180K ÷ $1,919,060K
= 0.04
The total asset turnover ratio for Vir Biotechnology Inc has shown significant fluctuations over the past five years. In 2023, the total asset turnover ratio was 0.04, indicating that the company generated $0.04 in revenue for every dollar of total assets.
Compared to the previous year, there was a substantial decrease from 0.58 in 2022 to 0.04 in 2023. This suggests a decline in the company's efficiency in generating revenue from its total assets.
The year 2021 saw a total asset turnover ratio of 0.56, which was relatively high compared to 2020 and 2019. This indicates that the company was more effective in utilizing its assets to generate revenue in 2021.
In contrast, the total asset turnover ratios for 2020 and 2019 were 0.08 and 0.02, respectively, reflecting lower efficiency in asset utilization during those years.
Overall, the total asset turnover ratio for Vir Biotechnology Inc has been volatile, with fluctuations indicating varying levels of efficiency in generating revenue from its total assets over the past five years. Further analysis would be needed to determine the underlying factors driving these fluctuations.
Peer comparison
Dec 31, 2023